Vanguard Healthcare ETF

Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

Цена последней сделки 231.49
Код ценной бумаги VHT
Полное наименование Vanguard Healthcare ETF
Объем 13828000000
Изм за день, % -0.01
Комиссия 0.10
Дата основания Jan 30. 2004
Ссылка ссылка
Тип актива Equity
Индекс MSCI US Investable Market Health Care 25/50 Index
Регион North America
Средний P/E 25.5
Дивиденды 1.16
5 летняя доходность 102.93
3 летняя доходность 51.04
Годовая доходность 21.71
Бета 0.84

Топ эмитентов

Эмитент Доля, %
Johnson & Johnson 7.5
UnitedHealth Group 6.3
Merck & Co 4
Thermo Fisher Scientific 3.62
Abbott 3.77
Danaher Corporation 2.82
AbbVie 3.51
Medtronic 3.01
Bristol-Myers 2.77
Amgen 2.56
Eli Lilly and Company 2.47
Intuitive Surgical 1.67
CVS Health Corporation 1.75
Stryker 1.55

Описание Vanguard Healthcare ETF

This ETF is one of many offering exposure to U.S. health care stocks, a corner of the domestic economy that has historically exhibited relatively low volatility. As a sector-specific ETF, VHT probably isn't all that useful in a long-term, buy-and-hold portfolio; most of the underlying companies will be included in broader U.S. equity products. This fund will be more attractive to those looking to put a tactical tilt towards health care stocks in place or as a tool in a sector rotation strategy. One noteworthy element of this ETF is the depth of holdings; with hundreds of individual stocks, VHT casts a considerably wider net than other health care ETFs such as XLV. But this fund is still somewhat concentrated; a small handful of stocks account for a significant portion of the total portfolio, while many of the smaller names have very minor weightings. VHT is also appealing from an expense perspective; the ER is one of the lowest in the ETFdb Category, and commission free trading in Vanguard accounts may further increase the appeal to cost conscious investors. Other options include XLV (for those seeking instant liquidity) and RYH, an equal-weighted fund that may be attractive for those looking to steer clear of market capitalization weighting methodologies.